LEVICEPT
With more than 1 billion people worldwide living with some type of chronic pain, a large unmet medical need for safe and effective analgesics exists. Traditional non-steroidal anti-inflammatory drugs (NSAIDs) are the most widely used drugs to treat pain and inflammation associated with osteoarthritis, but their use is limited by adverse effects on gastrointestinal and platelet function, as well as increased cardiovascular liability. Levicept is an asset-centric UK-based biotechnology company developing a novel, safe and efficacious biological therapy (LEVI-04 [p75NTR-Fc]) for the treatment of chronic pain. We are progressing LEVI-04 to phase I clinical trials to test its efficacy and safety in patients with osteoarthritis.
LEVICEPT
Industry:
Biopharma Biotechnology Medical Device
Founded:
2012-01-01
Address:
Sandwich, Kent, United Kingdom
Country:
United Kingdom
Website Url:
http://www.levicept.com
Total Employee:
1+
Status:
Active
Contact:
(447) 590-8153
Email Addresses:
[email protected]
Total Funding:
12.4 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Mobile Non Scaleable Content Nginx Euro Microsoft Exchange Online
Similar Organizations
Cue Biopharma
Cue Biopharma has developed a highly productive platform for the treatment of cancer and autoimmune disease.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Innovate UK
Innovate UK investment in Grant - Levicept
Gilde Healthcare
Gilde Healthcare investment in Series A - Levicept
Index Ventures
Index Ventures investment in Series A - Levicept
Advent Life Sciences
Advent Life Sciences investment in Series A - Levicept
Official Site Inspections
http://www.levicept.com Semrush global rank: 5.39 M Semrush visits lastest month: 1.56 K
- Host name: 768160.cloudwaysapps.com
- IP address: 134.209.17.126
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "Levicept"
Levicept - Crunchbase Company Profile & Funding
Levicept is an asset-centric UK-based biotechnology company developing a novel, safe and efficacious biological therapy (LEVI-04 [p75NTR-Fc]) for the treatment of chronic pain. We are …See details»
Levicept 2025 Company Profile: Valuation, Funding & Investors
Levicept General Information Description. Developer of a novel biological therapy designed to provide treatment for chronic pain. The company's therapy delivers neurotrophin homeostasis …See details»
Levicept Company Profile - Office Locations, Competitors ... - Craft
Levicept Ltd is an asset-centric UK-based biotechnology company developing a novel, safe and efficacious biological therapy (LEVI-04 [p75NTR-Fc]) for the treatment of chronic pain. We are …See details»
Levicept Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Levicept Ltd is a UK-based biotechnology company developing the first in a new class of novel, safe and efficacious biological therapies, LEVI-04 [p75NTR-Fc], for the treatment of …See details»
Levicept - Products, Competitors, Financials, Employees, …
Levicept is a biotechnology company that develops biological therapies aimed at treating chronic pain, particularly in osteoarthritis. The company is working on a therapy, LEVI-04, which aims …See details»
About Levicept - pharmiweb.jobs
Dec 14, 2023 Levicept Ltd is a UK-based biotechnology company developing a novel, safe and efficacious biological therapy (LEVI-04 [p75NTR-Fc]) for the treatment of chronic pain. LEVI …See details»
Levicept - Overview, News & Similar companies | ZoomInfo.com
Levicept received seed funding from Index Ventures, now Medicxi, in 2012, enabling the Company to deliver research test agent for preclinical studies, and preclinical proof-of-concept …See details»
About - Levicept
Levicept is a UK-based biotechnology company developing a novel, efficacious biological therapy, LEVI-04, for the treatment of chronic pain. With more than 1 billion people worldwide living …See details»
Levicept - Org Chart, Teams, Culture & Jobs - The Org
View Levicept's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Levicept - Gilde Healthcare
Levicept Ltd is a biopharmaceutical company developing a novel, safe and efficacious biological therapy (LEVI-04 [p75NTR-Fc]) for the treatment of chronic pain. The company is in clinical …See details»
Levicept - medicxiventures.com
Levicept discovered and is developing a novel first in class and safe biological agent (p75NTR-Fc) for the treatment of chronic pain. CEO. Eliot Forster. HQ. Sandwich, UK. Team Members. …See details»
Levicept - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Levicept . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Member and Advisor Profiles 2. Contacts 1. About. …See details»
Levicept - VentureRadar
Levicept Ltd is an asset-centric UK-based biotechnology company developing a novel, safe and efficacious biological therapy (LEVI-04 [p75NTR-Fc]) for the treatment of chronic pain. LEVI …See details»
Leadership Team - Levicept
Currently, he is on the Board of Sitryx Therapeutics (co-founder), Levicept, and he is the Chair of the Board of Citryll. Arthur Franken. Arthur Franken. Arthur Franken is a General Partner at …See details»
Levicept Presents Positive Phase II Data for Novel - GlobeNewswire
6 days ago Levicept Ltd is a UK-based biotechnology company developing the first in a new class of novel, safe and efficacious biological therapies, LEVI-04 [p75NTR-Fc], for the …See details»
Levicept Presents Positive Phase II Data for Novel ... - BioSpace
4 days ago Levicept Ltd is a UK-based biotechnology company developing the first in a new class of novel, safe and efficacious biological therapies, LEVI-04 [p75NTR-Fc], for the …See details»
Levicept - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Oct 8, 2014: Grant - Levicept . …See details»
Contact – Levicept
Contact. Levicept Ltd Innovation House Discovery Park Ramsgate Road Sandwich Kent CT13 9ND. [email protected] . LinkedIn; Levicept Ltd : Contact. Privacy PolicySee details»
News - Levicept
Positive Data from Levicept’s Phase II Study of LEVI-04. January 2025. Levicept Welcomes FDA Approval of First New Non-Opioid Treatment for Pain in Decades . November 2024. Levicept …See details»
Levicept emerges from Pfizer's R&D ashes with $20M and a new …
Oct 8, 2014 Rescued from Pfizer's sweeping R&D cuts, Levicept's lead drug is a protein with promise in chronic pain, and the biotech has raised $15.7 million in venture and grant funding …See details»